Vas Narasimhan, Novartis CEO (Gian Ehrenzeller/Keystone via AP Images)

No­var­tis re­port­ed­ly backs off ac­qui­si­tion of Cy­to­ki­net­ics – WSJ

Af­ter No­var­tis CEO Vas Narasimhan down­played ru­mors that his com­pa­ny want­ed to ac­quire the biotech Cy­to­ki­net­ics, the Wall Street Jour­nal re­port­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.